Net-Zero Pharma Supply Chain Market Revenue and Forecast by 2033

22 Jul 2025

Share :

Table of Content

1. Net-Zero Pharma Supply Chain Market Revenue and Trends 2025 to 2033 2. What are the Key Factors Boosting the Growth of the Net-Zero Pharma Supply Chain Market? 3. Segment Insights 4. Regional Insights 5. Net-Zero Pharma Supply Chain Market Coverage 6. Net-Zero Pharma Supply Chain Market Key Players

Net-Zero Pharma Supply Chain Market Revenue and Trends 2025 to 2033

The net-zero pharma supply chain market focuses on decarbonizing pharmaceutical logistics and manufacturing. It is driven by sustainability goals, regulatory mandates, and green innovation in packaging, energy, and transportation. The market is expanding due to rising regulatory pressures, increasing investor demand for sustainability, and the urgent need to reduce carbon emissions across the pharmaceutical industry.

What are the Key Factors Boosting the Growth of the Net-Zero Pharma Supply Chain Market?

The market for net-zero pharma supply chain is rapidly growing. Governments and health organizations around the world are pressuring the pharmaceutical sector to shift toward greener practices through regulations and sustainability mandates. Carbon-neutral products are in high demand among investors and consumers, driving pharmaceutical companies to decarbonize their value chain from start to finish. Technological advances, such as AI-driven logistics, blockchain, and energy-efficient cold chains, are making it possible to achieve net-zero goals without sacrificing efficiency. The rising cost of energy is pushing the industry toward renewable energy and a circular economy model. Moreover, growing concerns over climate change and its impact are pushing pharmaceutical companies to reduce their carbon footprints.

Segment Insights

• By scope in supply chain, the cold chain & logistics segment dominated the market in 2024. The dominance of this segment stems from the increased demand for sustainable logistics. Cold chain and logistics ensure the efficacy of temperature-sensitive drugs, reducing spoilage and carbon emissions.
• By components, the solutions segment held the dominant share of the market in 2024 due to the increased adoption of digital platforms that allow for carbon tracking in line with sustainable practices and overall supply chain optimization.
• By emission scope addressed, the scope 3 segment dominated the market with the largest share in 2023. This is mainly due to the increased focus of pharmaceutical companies on reducing indirect emissions, such as those from raw material sourcing and delivery of supplies.
• By deployment type, the cloud-based solutions led the market, accounted for the largest share in 2024. This is mainly due to the increased need for real-time analytics. Cloud-based solutions help track carbon footprints more effectively.
• By end-user, the pharmaceutical manufacturers segment registered dominance in the market, driven by their ambitious sustainability goals and increased spending on green supply chain solutions.
• By organization size, the large enterprises segment led the market, leveraging their wide-ranging resources to implement more innovative and sustainable solutions in support of global carbon-neutral targets.

Regional Insights

Europe dominated the net-zero pharma supply chain market with the largest share in 2024. This is mainly due to its ambitious sustainability goals and stringent regulations to reduce carbon footprints. Companies in this region are quickly deploying advanced carbon accounting tools, low-emission logistics systems, and renewable energy to decarbonize end-to-end operations.

Asia Pacific is expected to experience the fastest growth in the upcoming period. China, India, and Japan are ramping up investment in green manufacturing and sustainable supply chains, underpinned by national net-zero commitments and an emphasis on clean energy integration. The rising adoption of circular economy principles to minimize waste and extend the lifecycle of products further supports market growth.

Net-Zero Pharma Supply Chain Market Coverage

Recent Development

• In March 2025, in collaboration with Emirates SkyCargo and another leading airline, SkyCell unveiled its Net ZERO Reverse, a groundbreaking service designed to revolutionize pharmaceutical supply chains by significantly reducing carbon emissions. This solution eliminates the need for returning containers by air, reducing CO2 emissions by over 90% and permanently removing residual emissions. (Source: https://skycell.ch)

Net-Zero Pharma Supply Chain Market Key Players

• Amcor (Sustainable Packaging)
• Avery Dennison
• BCG (Net-Zero Practice for Life Sciences)
• Cardinal Health
• Catalent
• DHL Supply Chain
• Enablon (Wolters Kluwer)
• IBM (Sterling & Envizi)
• IQVIA
• McKinsey & Company (QuantumBlack for decarbonization)
• Microsoft (Sustainability Cloud)
• Oracle (Supply Chain Management Cloud)
• SAP SE
• Schneider Electric
• Siemens AG
• Sphera Solutions
• Thermo Fisher Scientific
• Tracelink
• UPS Healthcare
• Vizient

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/6437

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com |+1 804 441 9344